Skip to main content

Table1 Clinical characteristics of breast cancer patients

From: Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling

Characteristics

Lymph node status

N− (%)

Lymph node status

N+ (%)

Age (years)

 ≥ 50

12 (26%)

4 (19%)

 < 50

34 (74%)

17 (81%)

pT

 1

37 (80.4%)

10 (48%)

 2

8 (17.4%)

11 (52%)

 3

1 (2.2%)

0

Histological grade

 G1

9 (19.6%)

2 (9.5%)

 G2

24 (52.2%)

10 (47.7%)

 G3

13 (28.2%)

9 (42.8%)

pN

 0

46 (100%)

0

 1

0

14 (66.7%)

 2

0

2 (9.5%)

 3

0

5 (23.8%)

Age (years) of healthy women

 > 50

8 (57.1%)

 

 < 50

6 (42.9%)